Dyadic International And 2 Other US Penny Stocks To Watch

The U.S. stock market recently experienced a significant downturn, with major indices like the Dow Jones Industrial Average and the S&P 500 suffering their worst one-day losses in months due to concerns over interest rate policies. In this context, investors might consider exploring alternative investment areas such as penny stocks, which remain a relevant opportunity despite being considered somewhat niche today. These stocks often represent smaller or newer companies and can offer substantial growth potential when supported by strong financial foundations.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
Inter & Co (NasdaqGS:INTR)	$3.95	$1.93B	★★★★☆☆
QuantaSing Group (NasdaqGM:QSG)	$3.08	$108.87M	★★★★★★
BAB (OTCPK:BABB)	$0.905	$6.59M	★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)	$2.78	$87.36M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$67.38M	★★★★★★
Permianville Royalty Trust (NYSE:PVL)	$1.445	$47.52M	★★★★★★
CBAK Energy Technology (NasdaqCM:CBAT)	$0.80	$77.26M	★★★★★☆
Smith Micro Software (NasdaqCM:SMSI)	$0.9632	$17.69M	★★★★★☆
Zynerba Pharmaceuticals (NasdaqCM:ZYNE)	$1.30	$65.6M	★★★★★☆
Safe Bulkers (NYSE:SB)	$3.58	$381.2M	★★★★☆☆

Click here to see the full list of 739 stocks from our US Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Dyadic International (NasdaqCM:DYAI)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Dyadic International, Inc. is a biotechnology platform company that develops, produces, and sells enzymes and other proteins both in the United States and internationally, with a market cap of $42.90 million.

Operations: The company generates its revenue primarily from its biotechnology segment, amounting to $3.36 million.

Market Cap: $42.9M

Dyadic International, Inc., a biotechnology company with a market cap of US$42.90 million, reported significant revenue growth for the third quarter of 2024, reaching US$1.96 million from US$0.40 million the previous year. Despite this increase, the company remains unprofitable with a negative return on equity and is not expected to achieve profitability in the near term. Dyadic has more cash than debt and maintains sufficient cash runway for over a year at current free cash flow levels. However, shareholders have experienced dilution recently due to an increase in shares outstanding by 2.7%.

• Click here and access our complete financial health analysis report to understand the dynamics of Dyadic International.
• Review our growth performance report to gain insights into Dyadic International's future.

WM Technology (NasdaqGS:MAPS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: WM Technology, Inc. offers ecommerce and compliance software solutions for retailers and brands in the cannabis market both in the United States and internationally, with a market cap of approximately $204.40 million.

Operations: The company generates revenue of $183.31 million from its Software & Programming segment, serving the cannabis market.

Market Cap: $204.4M

WM Technology, Inc., with a market cap of US$204.40 million, is navigating challenges typical for penny stocks. Despite reporting US$183.31 million in revenue from its software solutions for the cannabis sector, the company remains unprofitable with increasing losses over five years. It trades significantly below estimated fair value, presenting potential opportunities but also risks due to high volatility and legal issues concerning inflated user metrics. Recent leadership changes include appointing a new CTO and CFO amidst ongoing class action lawsuits and Nasdaq compliance pressures regarding its stock price. The company's cash runway supports operations for over three years despite shrinking free cash flow.

• Navigate through the intricacies of WM Technology with our comprehensive balance sheet health report here.
• Evaluate WM Technology's prospects by accessing our earnings growth report.

FREYR Battery (NYSE:FREY)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: FREYR Battery, Inc. provides battery solutions in the United States, Norway, and internationally with a market cap of $247.26 million.

Operations: No revenue segments have been reported.

Market Cap: $247.26M

FREYR Battery, Inc., with a market cap of US$247.26 million, is a pre-revenue company navigating the challenges typical for penny stocks. It has no debt and its short-term assets of US$199.5 million comfortably cover both short- and long-term liabilities. However, it remains unprofitable with increasing losses over the past five years and significant insider selling recently observed. The company's management team is new, reflecting recent executive changes including the appointment of Daniel Barcelo as CEO following Tom Einar Jensen's resignation. Despite volatility in share price, FREYR secured a €122 million EU grant for its Finnish project development efforts.

• Click here to discover the nuances of FREYR Battery with our detailed analytical financial health report.
• Gain insights into FREYR Battery's outlook and expected performance with our report on the company's earnings estimates.

Key Takeaways

• Embark on your investment journey to our 739 US Penny Stocks selection here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com